Fred E. Cohen, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 54,250 shares at $5.42 ($294K) on 2017-09-18, disclosed to the SEC on 2017-09-20.
Seasonal sale ($294k) by Director — this insider has traded BCRX in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-02-26 | $1.6M | — | Filing → |
| GHDX | SELL | 2018-11-13 | $1.3M | — | Filing → |
| GHDX | SELL | 2018-09-10 | $1.0M | — | Filing → |